• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

Ciprofol comparable to propofol for general anesthesia induction for gynecological surgery

byKeerthana PasumarthiandAlex Chan
August 10, 2022
in Obstetrics, Surgery
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Ciprofol was just as effective to propofol for general anesthesia induction in patients undergoing gynecological surgery and presents fewer adverse events.

Evidence Rating Level: 1 (Excellent)

In anesthesia practice, propofol is traditionally used to induce and maintain general anesthesia. While it does have a strong utility, propofol also may cause several adverse effects such as the inhibition of the circulatory and respiratory systems. As such, alternative drug choices for general anesthesia are needed. Ciprofol is a newly developed, short-acting GABA receptor which has been thought to be more potent than propofol with minor residual side effects, although there is limited data available regarding its use. This randomized control trial aims to investigate the safety and efficacy of ciprofol when used to induce general anesthesia in individuals undergoing gynecological surgery, compared to propofol. A total of 120 women planned for gynecological surgery were randomly assigned to either ciprofol or propofol groups, and success rate of general anesthesia induction was assessed. The results of this study identified no significant differences between the ciprofol and propofol groups with regards to onset of successful anesthetic induction (35.4 vs 34.8, respectively). Additionally, for patients in the ciprofol group, blood pressure values decreased significantly less compared to the propofol group, suggesting a less adverse effect on the cardiovascular system. In conclusion, ciprofol is non-inferior to propofol when used for the induction of general anesthesia and poses less serious adverse events. However, this study continues to be limited as participants with pre-existing respiratory or cardiovascular conditions were not included in the study and the sample size was limited. As well, this study only examined patients undergoing gynecological surgery; however, patients undergoing other types of surgery may respond differently to these anesthetics. Nevertheless, as the findings of this study do support the efficacy and safety of ciprofol, further research is warranted.

Click to read the study in BMC Anesthesiology

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Medbridge turns any phone into a motion-capture coach for at-home rehab

Cerebral embolic protection does not decrease stroke incidence in TAVI patients

Minimally invasive surgery is beneficial for epithelial ovarian cancer 

Tags: anesthesiagynecologySurgery
Previous Post

Moderate-intensity statin plus ezetimibe is non-inferior to high-intensity statin monotherapy

Next Post

#VisualAbstract: Pharmacotherapy is effective for acute insomnia but with worse side effect profiles than placebo

RelatedReports

Active sexting among teens related to sexual activity
AI Roundup

Medbridge turns any phone into a motion-capture coach for at-home rehab

July 10, 2025
Cerebral protection device effective in patients undergoing transcatheter aortic valve implantation
Cardiology

Cerebral embolic protection does not decrease stroke incidence in TAVI patients

July 8, 2025
All Specialties

Minimally invasive surgery is beneficial for epithelial ovarian cancer 

July 4, 2025
Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial
Weekly Rewinds

2 Minute Medicine Rewind June 30, 2025

June 30, 2025
Next Post
#VisualAbstract: Dapagliflozin associated with reduced risk of cardiovascular and kidney outcomes irrespective of background use of cardiovascular medications

#VisualAbstract: Pharmacotherapy is effective for acute insomnia but with worse side effect profiles than placebo

Decline in adolescent sleep duration over past 20 years

Wellness Check: Sleep

The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]

The PIOPED II trial: CT sensitive and specific for pulmonary embolism [Classics Series]

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Obicetrapib Reduced LDL Cholesterol in Patients at High Cardiovascular Risk
  • St. Louis hospital-based violence intervention program did not significantly affect reinjury outcomes
  • Glucagon-like peptide-1 receptor agonists may increase risk of reflux in patients with type 2 diabetes
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.